• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生期 6-羟多巴胺损毁增强了在发育后期被喹吡罗预刺激的大鼠对喹吡罗诱导的垂直跳跃反应。

Neonatal 6-hydroxydopamine lesioning enhances quinpirole-induced vertical jumping in rats that were quinpirole primed during postnatal ontogeny.

机构信息

Department of Pharmacology, Quillen College of Medicine, East Tennessee State University, P.O. Box 70577, Johnson City, TN 37614, USA.

出版信息

Neurotox Res. 2012 Feb;21(2):231-5. doi: 10.1007/s12640-011-9268-5. Epub 2011 Aug 19.

DOI:10.1007/s12640-011-9268-5
PMID:21853388
Abstract

Quinpirole-induced vertical jumping is a phenomenon first observed in rats treated from birth, once a day for 21 days or more, with the dopamine D₂ receptor agonist quinpirole. This quinpirole-induced behavioral sensitization is known as a priming process. To determine whether dopaminergic innervation influenced this priming phenomenon, groups of rats were lesioned at 3 days after birth with the neurotoxin 6-hydroxydopamine (6-OHDA; 67 μg in each lateral ventricle; desipramine pretreatment, 20 mg/kg ip, 1 h). Rats were additionally treated daily from birth with quinpirole HCl (3.0 mg/kg ip, salt form). Controls received saline vehicle in place of 6-OHDA and/or quinpirole. When rats were placed in individual observation cages (1 h acclimation) starting at 20 days after birth, acute quinpirole treatment produced vertical jumping in the quinpirole-primed group; and the effect persisted through the twenty-ninth day. In rats additionally lesioned with 6-OHDA, vertical jumping was enhanced at 20, 24, 26/27, and 28/29 day--with there being as much as a 32-fold increase in vertical jumping versus the group that was primed with quinpirole, but not lesioned with 6-OHDA. This finding indicates that an ontogenetic 6-OHDA lesion enhances quinpirole-induced vertical jumping in rats and that dopaminergic innervation may normally exert a suppressive effect on vertical jumping.

摘要

喹吡罗诱导的垂直跳跃是一种首先在出生后每天接受多巴胺 D₂ 受体激动剂喹吡罗处理 21 天或更长时间的大鼠中观察到的现象。这种喹吡罗诱导的行为敏化被称为引发过程。为了确定多巴胺能神经支配是否影响这种引发现象,在出生后第 3 天用神经毒素 6-羟多巴胺(6-OHDA;每个侧脑室 67 μg;去甲丙咪嗪预处理,20 mg/kg ip,1 h)对大鼠进行分组损伤。大鼠从出生起每天还接受盐酸喹吡罗(3.0 mg/kg ip,盐形式)治疗。对照组用生理盐水代替 6-OHDA 和/或喹吡罗。当大鼠从出生后第 20 天开始被放置在单独的观察笼中(1 h 适应期)时,急性喹吡罗处理在喹吡罗引发组中产生垂直跳跃;并且该效果持续到第 29 天。在另外用 6-OHDA 损伤的大鼠中,垂直跳跃在第 20、24、26/27 和 28/29 天增强-与用喹吡罗引发但未用 6-OHDA 损伤的组相比,垂直跳跃增加了 32 倍。这一发现表明,发育性 6-OHDA 损伤增强了大鼠中喹吡罗诱导的垂直跳跃,并且多巴胺能神经支配可能对垂直跳跃正常发挥抑制作用。

相似文献

1
Neonatal 6-hydroxydopamine lesioning enhances quinpirole-induced vertical jumping in rats that were quinpirole primed during postnatal ontogeny.新生期 6-羟多巴胺损毁增强了在发育后期被喹吡罗预刺激的大鼠对喹吡罗诱导的垂直跳跃反应。
Neurotox Res. 2012 Feb;21(2):231-5. doi: 10.1007/s12640-011-9268-5. Epub 2011 Aug 19.
2
Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.个体发育过程中的喹吡罗治疗未能使6-羟基多巴胺损伤大鼠对D2激动剂增强的运动活动产生启动作用。
Neurotox Res. 2003;5(5):329-38. doi: 10.1007/BF03033153.
3
Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.阿扑吗啡引发改变了6-羟基多巴胺损伤大鼠纹状体流出通路对D2激动剂刺激的反应。
Neuroscience. 1997 Jul;79(1):79-93. doi: 10.1016/s0306-4522(96)00681-1.
4
Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.在6-羟基多巴胺损伤的大鼠中,需要预先刺激D1多巴胺受体来启动D2介导的纹状体Fos表达。
Neuroscience. 1999;94(2):505-14. doi: 10.1016/s0306-4522(99)00338-3.
5
Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors.咖啡因对6-羟基多巴胺损伤大鼠的运动刺激作用取决于先前对多巴胺受体的刺激:D1和D2受体的不同作用。
Eur J Neurosci. 1998 May;10(5):1878-84. doi: 10.1046/j.1460-9568.1998.00198.x.
6
Enhanced quinpirole response in rats lesioned neonatally with 5,7-dihydroxytryptamine.
Pharmacol Biochem Behav. 1995 Apr;50(4):649-53. doi: 10.1016/0091-3057(94)00328-9.
7
D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.D1 激动剂增强了 6-羟多巴胺损伤大鼠的 D1 和 D2 介导的旋转行为和纹状体 Fos 表达。
Pharmacol Biochem Behav. 2010 Jan;94(3):346-51. doi: 10.1016/j.pbb.2009.09.016. Epub 2009 Oct 2.
8
Ontogenetic quinpirole treatment induces vertical jumping activity in rats.个体发育过程中的喹吡罗治疗可诱导大鼠产生垂直跳跃活动。
Eur J Pharmacol. 1993 Aug 3;239(1-3):183-7. doi: 10.1016/0014-2999(93)90992-q.
9
Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.N-甲基-D-天冬氨酸谷氨酸受体在6-羟基多巴胺损伤大鼠中引发D2介导的旋转行为及纹状体Fos表达中的时间依赖性和作用
Brain Res. 1999 May 8;827(1-2):160-8. doi: 10.1016/s0006-8993(99)01325-6.
10
Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions.
Neurotoxicol Teratol. 1999 Mar-Apr;21(2):129-40. doi: 10.1016/s0892-0362(98)00044-0.

引用本文的文献

1
Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson's disease.大鼠新生期 6-羟多巴胺损毁与多巴胺能神经毒性:帕金森病拟似动物模型。
J Neural Transm (Vienna). 2022 Jun;129(5-6):445-461. doi: 10.1007/s00702-022-02479-4. Epub 2022 Mar 12.
2
Dopamine D Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders.多巴胺 D 受体超敏作为精神障碍神经毒性和状态的一个谱。
J Pharmacol Exp Ther. 2018 Sep;366(3):519-526. doi: 10.1124/jpet.118.247981. Epub 2018 Jun 19.
3
Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.

本文引用的文献

1
Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicability.多巴胺受体超敏反应:发生、机制、表现及临床应用
Neurotox Res. 2008 Oct;14(2-3):121-8. doi: 10.1007/BF03033804.
2
DSP-4 prevents dopamine receptor priming by quinpirole.DSP-4可防止喹吡罗引发多巴胺受体。
Pharmacol Biochem Behav. 2006 May;84(1):3-7. doi: 10.1016/j.pbb.2006.03.024. Epub 2006 May 3.
3
Dopamine D2 agonist priming in intact and dopamine-lesioned rats.完整和多巴胺损伤大鼠中的多巴胺D2激动剂引发作用
围产期使用多巴胺D₂受体激动剂喹吡罗治疗会导致永久性D₂受体超敏反应:一种精神分裂症模型
Neurochem Res. 2016 Feb;41(1-2):183-92. doi: 10.1007/s11064-015-1757-0. Epub 2015 Nov 7.
4
Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.与帕金森病相关的神经毒素机制及过程:最新进展
Neurotox Res. 2015 Apr;27(3):328-54. doi: 10.1007/s12640-015-9519-y. Epub 2015 Jan 29.
Neurotox Res. 2004;6(6):457-62. doi: 10.1007/BF03033281.
4
Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.个体发育过程中的喹吡罗治疗未能使6-羟基多巴胺损伤大鼠对D2激动剂增强的运动活动产生启动作用。
Neurotox Res. 2003;5(5):329-38. doi: 10.1007/BF03033153.
5
Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats.个体发育过程中的喹吡罗治疗会导致成年大鼠出现空间记忆缺陷并增强其熟练抓握能力。
Pharmacol Biochem Behav. 2002 Jun;72(3):591-600. doi: 10.1016/s0091-3057(02)00730-x.
6
Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates.在新生大鼠中用喹吡罗预处理后,苯丙胺对大鼠体内新纹状体微透析液多巴胺含量的增强作用。
Pol J Pharmacol. 2001 Jul-Aug;53(4):319-29.
7
7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats.与喹吡罗不同,7-羟基二苯丙氨酸不会引发大鼠的打哈欠反应。
Pharmacol Biochem Behav. 2000 Sep;67(1):11-5. doi: 10.1016/s0091-3057(00)00296-3.
8
Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications.尼古丁可阻断喹吡罗对大鼠行为的影响:精神病学意义。
Psychopharmacology (Berl). 1999 Aug;145(4):433-41. doi: 10.1007/s002130051078.
9
Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain.大鼠大脑中血清素神经对多巴胺神经元个体发育丧失的适应性变化
J Neurochem. 1998 Mar;70(3):889-98. doi: 10.1046/j.1471-4159.1998.70030889.x.
10
Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats.6-羟基多巴胺损伤对大鼠SKF 38393和间氯苯哌嗪诱导的口腔活动反应的年龄依赖性。
Brain Res Dev Brain Res. 1993 Nov 19;76(1):87-93. doi: 10.1016/0165-3806(93)90126-u.